Syed Ahsan Ali Shah et al. 2024. BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL. Journal of Population Therapeutics and Clinical Pharmacology. 31, 3 (Mar. 2024), 622–629. DOI:https://doi.org/10.53555/jptcp.v31i3.4993.